Dyslipidemia in South Asians living in a western community

Journal of Clinical Lipidology

Volumn 3, Issue 1, 2009, Pages 14-18

  Kolluri, Raghu ^a   Pinedo, Daryl ^b   Edmondson Holt, Ardis ^c   Grewal, Kanny S ^c,d   Falko, James M ^e  

^a Prairie Vascular Institute   (United States)

^b Saint Luke's Brain and Stroke Institute Kansas City   (United States)

^c RIVERSIDE METHODIST HOSPITAL   (United States)

^d MidOhio Cardiology and Vascular Consultants   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

CRP; Dyslipidemia; Indian; LP (a); South Asian

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ASIAN; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; SOUTH ASIA; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

NICOTIANA TABACUM;

EID: 59449088838     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2008.12.002     Document Type: Review

References (46)

1. Lee J., Heng D., Chia K.S., Chew S.K., Tan B.Y., and Hughes K. Risk factors and incident coronary heart disease in Chinese, Malay and Asian Indian males: the Singapore Cardiovascular Cohort Study. Int J Epidemiol 30 (2001) 983-988
2. Mohan V., Deepa R., Rani S.S., and Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol 38 (2001) 682-687
3. Srinath Reddy K., Shah B., Varghese C., and Ramadoss A. Responding to the threat of chronic diseases in India. Lancet 366 9498 (2005) 1744-1749
4. Joshi P., Islam S., Pais P., et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 297 (2007) 286-294
5. Dhawan J., Bray C.L., Warburton R., Ghambhir D.S., and Morris J. Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians. Genetic or environmental effect?. Br Heart J 72 (1994) 413-421
6. Hughes L.O., Wojciechowski A.P., and Raftery E.B. Relationship between plasma cholesterol and coronary artery disease in Asians. Atherosclerosis 83 (1990) 15-20
7. McKeigue P.M., Miller G.J., and Marmot M.G. Coronary heart disease in south Asians overseas: a review. J Clin Epidemiol. 42 (1989) 597-609
8. Control CfD. Prevalence of cigarette use among 14 racial/ethnic populations-United States, 1999-2001. MMWR 53 (2004) 49-52
9. WHO. Tobacco or health: a global status report (1997), World Health Organization, Geneva
10. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
11. Kooner J.S., Baliga R.R., Wilding J., et al. Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature myocardial infarction. Arterioscler Thromb Vasc Biol. 18 (1998) 1021-1026
12. McKeigue P.M., Shah B., and Marmot M.G. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337 (1991) 382-386
13. Zoratti R., Godsland I.F., Chaturvedi N., Crook D., Stevenson J.C., and McKeigue P.M. Relation of plasma lipids to insulin resistance, nonesterified fatty acid levels, and body fat in men from three ethnic groups: relevance to variation in risk of diabetes and coronary disease. Metabolism 49 (2000) 245-252
14. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
15. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
16. Hodge A.M., Dowse G.K., Collins V.R., et al. Abdominal fat distribution and insulin levels only partially explain adverse cardiovascular risk profile in Asian Indians. J Cardiovasc Risk 3 (1996) 263-270
17. Jeyarajah E.J., Cromwell W.C., and Otvos J.D. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 26 (2006) 847-870
18. Grewal K.S., Kolluri R., and Patel A. Prevalence of Lipid triad, lipoprotein (a) and C-reactive protein in a screening population of South Asian women: implications for heart disease in Asian American women (2005), Second International Conference on Women, Heart Disease and Stroke (American Heart Association), Orlando, HL
19. France M.W., Kwok S., McElduff P., and Seneviratne C.J. Ethnic trends in lipid tests in general practice. QJM 96 (2003) 919-923
20. Gama R., Elfatih A.B., and Anderson N.R. Ethnic differences in total and HDL cholesterol concentrations: Caucasians compared with predominantly Punjabi Sikh Indo-Asians. Ann Clin Biochem 39 Pt 6 (2002) 609-611
21. McKeigue P.M., Marmot M.G., Adelstein A.M., et al. Diet and risk factors for coronary heart disease in Asians in northwest London. Lancet 2 (1985) 1086-1090
22. Bhalodkar N.C., Blum S., Rana T., et al. Comparison of levels of large and small high-density lipoprotein cholesterol in Asian Indian men compared with Caucasian men in the Framingham Offspring Study. Am J Cardiol 94 (2004) 1561-1563
23. Enas E.A. Coronary artery disease epidemic in Indians: a cause for alarm and call for action. J Indian Med Assoc. 98 (2000) 694-695 697-702
24. Julius U., Dittrich M., and Pietzsch J. Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance. Int J Clin Pract 61 (2007) 1798-1804
25. Kulkarni K.R., Markovitz J.H., Nanda N.C., and Segrest J.P. Increased prevalence of smaller and denser LDL particles in Asian Indians. Arterioscler Thromb Vasc Biol 19) (1999) 2749-2755
26. Danesh J., Collins R., Peto R., and Lowe G.D. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J 21 (2000) 515-520
27. Gupta R., Deedwania P.C., Gupta A., et al. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol 97 (2004) 257-261
28. Rajeshwari R., Nicklas T., Pownall H., and Berenson G. Cardiovascular diseaes: a major health risk in Asian Indians. Nutr Res. 25 (2005) 515-533
29. Barrett-Connor E.L., Cohn B.A., Wingard D.L., and Edelstein S.L. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 265 (1991) 627-631
30. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
31. Schrott H.G., Bittner V., Vittinghoff E., Herrington D.M., and Hulley S. Adherence to National Cholesterol Education Program treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group. JAMA 277 (1997) 1281-1286
32. Palaniappan L., Wang Y., and Fortmann S.P. Coronary heart disease mortality for six ethnic groups in California, 1990-2000. Ann Epidemiol 14 (2004) 499-506
33. Gambhir J.K., Kaur H., Gambhir D.S., and Prabhu K.M. Lipoprotein(a) as an independent risk factor for coronary artery disease in patients below 40 years of age. Indian Heart J 52 (2000) 411-415
34. Isser H.S., Puri V.K., Narain V.S., Saran R.K., Dwivedi S.K., and Singh S. Lipoprotein (a) and lipid levels in young patients with myocardial infarction and their first-degree relatives. Indian Heart J 53 (2001) 463-466
35. Bhatnagar D., Anand I.S., Durrington P.N., et al. Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet 345 (1995) 405-409
36. Hopkins P.N., Wu L.L., Hunt S.C., James B.C., Vincent G.M., and Williams R.R. Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease. Arterioscler Thromb Vasc Biol 17 (1997) 2783-2792
37. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
38. Rutter M.K., Meigs J.B., Sullivan L.M., D'Agostino Sr. R.B., and Wilson P.W. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110 (2004) 380-385
39. Anand S.S., Razak F., Yi Q., et al. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol 24 (2004) 1509-1515
40. O'Callaghan P., Meleady R., Fitzgerald T., and Graham I. Smoking and plasma homocysteine. Eur Heart J 23 (2002) 1580-1586
41. Clarke R., Collins R., and Lewington S. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288 (2002) 2015-2022
42. Foody J.M., Milberg J.A., Robinson K., et al. Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women. Arterioscler Thromb Vasc Biol 20 (2000) 493-499
43. Refsum H., Yajnik C.S., Gadkari M., et al. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr 74 (2001) 233-241
44. Chambers J.C., Obeid O.A., Refsum H., et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 355 (2000) 523-527
45. Obeid O.A., Mannan N., Perry G., Iles R.A., and Boucher B.J. Homocysteine and folate in healthy east London Bangladeshis. Lancet 352 (1998) 1829-1830
46. Bazzano L.A., Reynolds K., Holder K.N., and He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 296 (2006) 2720-2726